D. E. Shaw & Co »

Candel Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 109k 10.30
2022-03-31 $55k 11k 5.06
2021-12-31 $79k 10k 7.80

More positions owned by D. E. Shaw & Co

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices Put Option (AMD)
Amazon (AMZN)
Micron Technology Put Option (MU)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Bloom Energy Corp Com Cl A Put Option (BE)
Crowdstrike Hldgs Cl A Put Option (CRWD)
Sandisk Corp (SNDK)

View all positions for D. E. Shaw & Co

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics